These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 217177)

  • 21. Familial hyperlipoproteinemia in a South Indian family.
    Rajagopal G; Chandrasekar S; Venugopala Rao A; Ramakrishnan S
    J Assoc Physicians India; 1975 Jan; 23(1):9-11. PubMed ID: 172484
    [No Abstract]   [Full Text] [Related]  

  • 22. Altering lipid patterns in adult males.
    Appelbaum JJ; Amundsen MA; Perkin DK
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the hypolipidemic action of sunflower oil and "Zdorov'e" margarine incorporated into the anti-atherosclerotic diet of ischemic heart disease patients].
    Meshcheriakova VA; Samsonov MA; Levachev MM; Iazeva LI; Stetsenko AV
    Vopr Pitan; 1987; (1):10-3. PubMed ID: 3564379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G; Fellin R
    Ann Biol Clin (Paris); 1974; 32(4):309-22. PubMed ID: 4376343
    [No Abstract]   [Full Text] [Related]  

  • 26. [Typology of the hyperlipoproteinemias in ischemic heart disease].
    Zakharova VN; Afanas'eva ON; Andrushchenko ES; Naumova LV; Zarudina IN
    Kardiologiia; 1977 Dec; 17(12):105-8. PubMed ID: 202776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein metabolism in liver disease.
    Green PH
    Lab Res Methods Biol Med; 1983; 7():199-204. PubMed ID: 6353105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma].
    Kulikov VI; Muzia GI; Bergel'son LD
    Biokhimiia; 1984 Sep; 49(9):1449-55. PubMed ID: 6542803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypercholesterolemia: mechanism of inheritance.
    de Oya M; Nuno J; Azpeitia AG; Villasante JG
    Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation of lecithin:cholesterol acyl transfer by intravenous injection of heparin.
    Schauer UJ; Schauer I; Rühling K; Thielmann K
    Biomed Biochim Acta; 1984; 43(10):1165-72. PubMed ID: 6525190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of lipids in blood plasma.
    Norum KR
    Bibl Nutr Dieta; 1977; (25):70-7. PubMed ID: 199156
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 34. [Familial congenital type IIB hyperlipoproteinemia].
    Di Gruttola G; Ferrara M
    Pediatria (Napoli); 1977 Sep; 85(3):435-42. PubMed ID: 201914
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cholesterol, free cholesterol, HDL, LDL, triglycerides, LCAT. Evaluation of some risk factors for cardiovascular diseases].
    Andreoli D; Lattuada L; Giovanelli E; Persico D
    Quad Sclavo Diagn; 1982 Jun; 18(2):127-31. PubMed ID: 7167633
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in serum lipoproteins and in lecithin: cholesterol acyltransferase activity with dietary fat modification.
    Weisweiler P; Schwandt P
    Adv Exp Med Biol; 1987; 210():183-7. PubMed ID: 3591548
    [No Abstract]   [Full Text] [Related]  

  • 37. [The LDL VLDL heparin Ca++ complex and the detectability of hyperlipoproteinemia in mass examination].
    Makurat D
    Wiad Lek; 1977 Dec; 30(23):1797-800. PubMed ID: 203123
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of preparations of polyunsaturated fatty acids on the level of blood serum lipoproteins in patients with ischemic heart disease].
    Britov AN; Shmushkovich BI; Karmanskiĭ IM
    Sov Med; 1976 Jan; (1):118-23. PubMed ID: 179152
    [No Abstract]   [Full Text] [Related]  

  • 39. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R; Salel AF
    Chest; 1973 Oct; 64(4):486-90. PubMed ID: 4355275
    [No Abstract]   [Full Text] [Related]  

  • 40. Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia.
    Cucuianu M; Opincaru A; Tapalagă D
    Clin Chim Acta; 1978 Apr; 85(1):73-9. PubMed ID: 647966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.